Clinical outcomes of patients with lung cancer treated with radiotherapy and ANTI-PD-1 therapy: A multicenter retrospective analysis from GFPC Group.

e21077Background: Anti-PD-1 therapy with nivolumab has demonstrated improved overall survival (OS) in patients with non-small-cell-lung cancer (NSCLC). Indeed, since CheckMate 017 and 057 results, ...